A detailed history of Collective Family Office LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Collective Family Office LLC holds 6,416 shares of NVO stock, worth $562,362. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,416
Previous 5,806 10.51%
Holding current value
$562,362
Previous $828,000 7.85%
% of portfolio
0.21%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$119.07 - $145.42 $72,632 - $88,706
610 Added 10.51%
6,416 $763,000
Q2 2024

Jul 05, 2024

BUY
$122.71 - $146.91 $3,313 - $3,966
27 Added 0.47%
5,806 $828,000
Q1 2024

Apr 09, 2024

BUY
$102.11 - $135.92 $68,413 - $91,066
670 Added 13.11%
5,779 $742,000
Q4 2023

Jan 09, 2024

BUY
$87.78 - $105.45 $448,468 - $538,744
5,109 New
5,109 $528,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Collective Family Office LLC Portfolio

Follow Collective Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Collective Family Office LLC with notifications on news.